Meanwhile, Avastin failed its first big clinical trial in breast cancer, raising doubts about whether it would work in colon cancer.
And perhaps most intriguing of all, the same kidney drug seems to have big potential for treating advanced breast cancer.
Sutent, a targeted cancer pill, could become a big drug if ongoing studies in breast cancer prove effective.
He added: "This South African athlete couldn't have AIS because her problem is that it is suggested that she looks rather male, she's got a big jaw and has very little breast development, but so many athletes are like that, " he added.
You see, the big loser in this story will be future breast cancer victims who may not get the diagnostic services or treatment required to save their lives as a result of what is sure to be a drop in funding for the Komen effort.
FORBES: A Black Mark On The Pink Ribbon: Politics Trump Breast Cancer
The company is a big provider of equipment for detection and treatment of breast and cervical cancer, as well as osteoporosis.
In another study of RAD in breast cancer, three out of of 22 patients had big tumor shrinkage, while the disease stabilized in another 13 for prolonged periods.
After the party ends, early for my sake, we put a big turkey in the oven (after a day of brining) breast down for extra juiciness, and cook it slowly all night.
FORBES: Do Yourself A Favor And "Voucherize" The Christmas Thing
Although I might quibble with the exact numbers in the piece, the big picture is this: BRCA1 increases the risk of developing breast cancer about five fold and increases the risk of ovarian cancer more than 10 fold.
Although I might quibble with the exact numbers in the piece, the big picture is this: the mutation increases the risk of developing breast cancer about five fold and increases the risk of ovarian cancer more than 10 fold.
He participates in nearly every big-name fundraiser that takes place in Montreal, including those for breast cancer, Lou Gehrig's disease and cystic fibrosis.
Breast-feeding advice, food supplements and better hygiene all make a big difference.
The drug is Pfizer's first big entry into the market for targeted cancer drugs, and is being tested in breast, colorectal, and lung cancers.
Immunogen suffered a big setback in August when the FDA refused to even consider approving the new T-DM1 breast cancer drug its partner Roche is testing based on its technology.
Novartis is conducting a big study to see whether the dug can also prevent relapse in the much bigger group of postmenopausal women with breast cancer.
应用推荐